BETA vs VRTX · rev $8.9M vs P/E 30, rev $12.00B
Beta Technologies, Inc. (BETA) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Beta Technologies, Inc. (BETA) is a aerospace & defense company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported BETA revenue for 2025-09-30 was $8.9M. Net income was -$437.2M. Revenue was up 190.9% from 2024-09-30 to 2025-09-30. BETA currently screens at market cap $3.72B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
BETA currently screens at market cap $3.72B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the BETA and VRTX stock pages for the full models.
Not investment advice.